Rituximab-mediated depletion of cynomolgus monkey B cells in vitro in different matrices: possible inhibitory effect of IgG.
about
Immune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodiesTwo mechanisms of the enhanced antibody-dependent cellular cytotoxicity (ADCC) efficacy of non-fucosylated therapeutic antibodies in human blood.Engineered antibody Fc variants with enhanced effector function.The emerging importance of α-L-fucose in human breast cancer: a review.Bispecific anti-CD20/22 antibodies inhibit B-cell lymphoma proliferation by a unique mechanism of action.Non-fucosylated therapeutic antibodies: the next generation of therapeutic antibodies.Biodistribution mechanisms of therapeutic monoclonal antibodies in health and disease.Production of therapeutic antibodies with controlled fucosylation.Rituximab: a review of dermatological applications.Glycosylation: impact, control and improvement during therapeutic protein production.Adjuvant rituximab therapy in pemphigus: a single-center experience of 18 cases.Optimization of humanized IgGs in glycoengineered Pichia pastoris.
P2860
Q28069362-66F0414C-899B-43E9-85A0-875324ED38CDQ33410392-6A7BF590-D6DA-4916-838A-F0B0194EE711Q34424958-9437B277-BCA8-4890-B769-D1024708464FQ35172546-03ED2476-B703-49A3-BC15-181A8AC8AD7EQ36445879-B73A4FD8-A858-4318-873E-07F2939B3211Q37323537-1B2B335B-C91D-4027-BE6F-98F121A896A7Q37635011-1D2E2936-74A5-469E-9EA9-A01BC0657563Q37672128-690CB84D-3152-4070-A366-4052900F5D8BQ37781697-F322310A-86CA-4F0E-8C21-FACC2ABFFAD1Q38126913-4D027322-3550-483D-8C83-6E80D0CC74AAQ45117048-B3FE08B9-CAAC-4D85-A9EA-3C9E0F300DEDQ51284070-ED59572F-6EBE-4CFB-8CEE-E632F4E4F4A3
P2860
Rituximab-mediated depletion of cynomolgus monkey B cells in vitro in different matrices: possible inhibitory effect of IgG.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Rituximab-mediated depletion o ...... ible inhibitory effect of IgG.
@en
Rituximab-mediated depletion o ...... ible inhibitory effect of IgG.
@nl
type
label
Rituximab-mediated depletion o ...... ible inhibitory effect of IgG.
@en
Rituximab-mediated depletion o ...... ible inhibitory effect of IgG.
@nl
prefLabel
Rituximab-mediated depletion o ...... ible inhibitory effect of IgG.
@en
Rituximab-mediated depletion o ...... ible inhibitory effect of IgG.
@nl
P1476
Rituximab-mediated depletion o ...... ible inhibitory effect of IgG.
@en
P2093
Kathy Howell
Yulia Vugmeyster
P304
P356
10.1016/J.INTIMP.2004.04.015
P577
2004-08-01T00:00:00Z